Pediatrix Medical Group (NYSE:MD) Stock Price Down 5.1% – Time to Sell?

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) were down 5.1% during mid-day trading on Tuesday . The company traded as low as $24.44 and last traded at $24.7960. 222,207 shares were traded during trading, a decline of 72% from the average session volume of 797,997 shares. The stock had previously closed at $26.14.

Pediatrix Medical Group News Summary

Here are the key news stories impacting Pediatrix Medical Group this week:

• Positive Sentiment: Pediatrix Medical Group provided a second-quarter update saying its payor mix remained stable and unchanged versus recent historical trends, which should ease investor concerns about reimbursement or utilization pressures in the business. Pediatrix Medical Group Provides Second Quarter Update
• Positive Sentiment: Truist Financial raised its price target on MD from $23 to $28, signaling improved confidence in the stock’s outlook despite keeping a hold rating. Truist Financial Issues Positive Forecast for Pediatrix Medical Group (NYSE:MD) Stock Price
• Positive Sentiment: Zacks published additional commentary labeling Pediatrix Medical Group a strong long-term growth and momentum name, which may support sentiment among growth-oriented investors. Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Zacks also highlighted MD as a top momentum stock for the long term, reinforcing ongoing investor interest but not providing a new fundamental catalyst. Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
• Negative Sentiment: Unusual options trading showed a surge in put buying, with traders purchasing 6,020 puts versus a typical 337, suggesting some market participants are positioning for downside risk or increased volatility.

Analyst Ratings Changes

Several brokerages have commented on MD. UBS Group upped their price objective on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a report on Friday, May 8th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $23.33.

Pediatrix Medical Group Trading Up 7.7%

The stock has a market capitalization of $2.13 billion, a P/E ratio of 12.60 and a beta of 0.66. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The company has a 50-day moving average price of $23.80 and a 200 day moving average price of $22.13.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.33 earnings per share. On average, research analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Insider Activity at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of large investors have recently made changes to their positions in the business. Phocas Financial Corp. raised its holdings in shares of Pediatrix Medical Group by 44.5% in the fourth quarter. Phocas Financial Corp. now owns 335,551 shares of the company’s stock worth $7,177,000 after buying an additional 103,328 shares during the last quarter. Ritholtz Wealth Management purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at $2,163,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at $13,613,000. Teacher Retirement System of Texas increased its position in shares of Pediatrix Medical Group by 25.6% in the 4th quarter. Teacher Retirement System of Texas now owns 306,715 shares of the company’s stock valued at $6,561,000 after acquiring an additional 62,446 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in Pediatrix Medical Group by 20.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 827,075 shares of the company’s stock worth $13,854,000 after acquiring an additional 140,577 shares during the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.